Why OHDSI Europe?
Strengthening Evidence Generation — Across Europe
Europe’s health data landscape is diverse. Countries use different coding systems, data structures, and governance frameworks. OHDSI Europe brings these efforts together to support more consistent, collaborative, and scalable evidence generation across borders.
- Supporting consistent OMOP adoption across national contexts
- Connecting local expertise to a European network
- Helping institutions participate in federated research
- Sharing best practices, tools, and training across borders
This coordinated approach ensures that European data can be used to generate trustworthy, large-scale evidence — without compromising privacy or local control.
-
European National Nodes
100+
Data Partners in Europe
3,000+
Publications using OMOP globally
80+
Countries in OHDSI network
-
Community members worldwide
Latest in Europe
Updates from the European OHDSI Community
Stay informed about community calls, implementation updates, study announcements, and major events from across Europe.
Impact in Europe
Real Evidence. Real Networks. Real Results.
From pharmacovigilance to public health and chronic disease research, OHDSI Europe supports large-scale, federated analyses across millions of patient records — without moving any data.
Our community collaborates through shared OMOP implementations, coordinated National Nodes, and Europe-wide research programmes.
European collaborations: SOPHIA, EHDEN, HERON-UK, PV Clinical, Indicate, and more.